Disclosure of a pro-apoptotic glyceraldehyde-3-phosphate dehydrogenase promoter: anti-dementia drugs depress its activation in apoptosis
- 1 May 2004
- journal article
- Published by Elsevier in Life Sciences
- Vol. 74 (26) , 3245-3258
- https://doi.org/10.1016/j.lfs.2003.11.029
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 35 references indexed in Scilit:
- Pharmacologic treatments of dementiaPublished by Elsevier ,2005
- GAPDH knockdown rescues mesencephalic dopaminergic neurons from MPP+-induced apoptosisNeuroReport, 2001
- Genetic Classification of Primary Neurodegenerative DiseaseScience, 1998
- Overexpression of Glyceraldehyde-3-Phosphate Dehydrogenase Is Involved in Low K+-Induced Apoptosis but Not Necrosis of Cultured Cerebellar Granule CellsMolecular Pharmacology, 1997
- Glyceraldehyde-3-phosphate dehydrogenase antisense oligodeoxynucleotides protect against cytosine arabinonucleoside-induced apoptosis in cultured cerebellar neurons.Proceedings of the National Academy of Sciences, 1996
- Evidence that Glyceraldehyde‐3‐Phosphate Dehydrogenase Is Involved in Age‐Induced Apoptosis in Mature Cerebellar Neurons in CultureJournal of Neurochemistry, 1996
- Uracil DNA-glycosylase/glyceraldehyde-3-phosphate dehydrogenase is an Ap4A binding proteinBiochemistry, 1995
- Possible mechanisms of action of (−)deprenyl and other MAO-B inhibitors in some neurologic and psychiatric disordersProgress in Neurobiology, 1994
- Tacrine: A pharmacological reviewProgress in Neurobiology, 1991
- Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic familyNucleic Acids Research, 1985